Gallen conference in 2013, categorizing breast cancer into four subtypes: luminal A, luminal B, Human Epidermal Growth Factor Receptor 2 (HER-2) overexpression, and Triple Negative Breast Cancer (TNBC). The gene discussed is ERBB2; the disease is breast carcinoma.